; Clinical Nutrition Market Size, Share and Forecasts to 2031

Clinical Nutrition Market

Clinical Nutrition Market: By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Others); By End User (Pediatric, Adults and Geriatric), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031

Published on: Jun-2023
Report Code: FG HC 01594
No. of Pages: 170-350
Report Format: PDF

Product Overview

Clinical Nutrition Market to surpass USD 27.16 billion by 2031 from USD 14.13 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-31.

Clinical nutrition product is a type of pharmaceutical product that aids in the maintenance of a patient's health. It contributes to the improvement of the metabolic system by providing adequate supplements such as minerals, vitamins, and other nutrients. Clinical nutrition diagnoses and treats diseases that affect the intake, intestinal absorption, and metabolism of dietary constituents, as well as promotes health through diet-related disease prevention. It is applicable in both acute and ambulatory care settings, such as cardiac rehabilitation, renal dialysis, diabetes, paediatrics, nutrition support, cancer, trauma, wellness centres, and community-based intervention programmes.

Market Highlights

Global Clinical Nutrition Market is expected to project a notable CAGR of 6.4% in 2031.

Global Clinical Nutrition Market to surpass USD 27.16 billion by 2031 from USD 14.13 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-31. The rise in the prevalence of metabolic disorders, high healthcare spending, and the rise of the middle class in emerging economies are driving the global clinical nutrition market's growth. Furthermore, the growing elderly population and the development of clinical nutrition products tailored to the needs of the elderly are expected to fuel market growth.

Clinical Nutrition Market

Global Clinical Nutrition Market: Segments

Cancer segment to grow with the highest CAGR during 2021-31

Based on application, global Clinical Nutrition Market is fragmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Others. During the forecasted period, cancer held the largest market share. The growing geriatric population base, combined with an increase in the number of people suffering from chronic conditions such as cancer and diabetes, is expected to drive the market over the forecast timeframe. The rising prevalence of chronic diseases has prompted an increase in clinical nutrition prescriptions, as patients suffering from such conditions are deficient in a number of essential nutrients. Furthermore, the growing obesity population as a result of poor dietary habits and physical inactivity will drive industry growth.

Pediatric segment to grow with the highest CAGR during 2021-31

Global Clinical Nutrition Market is classified on the basis of end user into Pediatric, Adults and Geriatric. In the forecasted period, the pediatric segment is expected to grow at a rapid pace due to rising malnutrition rates and preterm birth rates worldwide.

Poverty and overpopulation are two other factors that contribute to the spread of malnutrition in developing countries.

Clinical Nutrition Market

Market Dynamics

Drivers

Rising prevalence of chronic diseases and poverty

The rising prevalence of chronic diseases such as cancer and cardiovascular disorders, malnutrition, respiratory diseases, and gastrointestinal diseases among children and adults is contributing to an increase in the demand for nutritional assistance. Malnutrition, micronutrient deficiency, and dehydration are common in patients suffering from neurological diseases. Multiple sclerosis, Parkinson's disease, and oropharyngeal dysphagia are a few examples of such neurological ailments. Oropharyngeal dysphagia, which is most common in the elderly population, is also common in dementia patients. Poverty and overpopulation are two other factors that contribute to the spread of malnutrition in developing countries.

Research and Development

Increase in research and development is expected to spur growth in clinical nutrition market. Companies are implementing collaborative business tactics to boost efficiency, supply consumers with high-quality products, and extend their geographical presence.

Restraint

Lack of awareness and stringent government regulations

Lack of awareness, particularly in developing countries, and stringent government regulations are just a few of the constraints that may lead to a lower adoption of alternative nutrition methods. Clinical nutrition market growth may be hampered in the world's least developed regions, where living standards are lower, due to a refusal of rationalised means of consuming nutrition and a lack of acceptance of newer approaches.

Global Clinical Nutrition Market:

Key Players

  • Nestle SA
  • Baxter International Inc
  • Abbott Laboratories
  • Braun Melsungen AG
  • GroupeDanone
  • Mead Johnson Nutrition Company
  • Fresenius Kabi AG
  • Hospira Inc
  • Perrigo Company Plc
  • Other Prominent Players

     (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Clinical Nutrition Market: Regions

Global Clinical Nutrition Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America accounted for the largest share and is expected to maintain its dominance due to high R&D spending, the presence of major players and their product availability, and the region's well-established healthcare infrastructure. However, Asia-Pacific is expected to have the highest CAGR during the forecast period, as Asian governments invest in healthcare infrastructure development.

Clinical Nutrition Market

COVID-19 pandemic on Clinical Nutrition Market

The COVID-19 pandemic is expected to have a significant impact on the clinical nutrition products market, as the demand for nutritional management, particularly among children and the elderly, continues to rise. The demand for clinical nutrition products is increasing as consumers seek various immunity-boosting alternatives to avoid becoming infected with the novel coronavirus. The infection also causes a loss of appetite, as well as other symptoms like anosmia dysgeusia or diarrhoea, which both increase the risk of disease-related malnutrition.

Global Clinical Nutrition Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global Clinical Nutrition Market report also contains analysis on:

Clinical Nutrition Market Segments:

  • By Application
    • Cancer 
    • Neurological Diseases
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Others
  • By End use
    • Pediatric
    • Adults
    • Geriatric
  • Clinical Nutrition Market Dynamics
  • Clinical Nutrition Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Clinical Nutrition Market Report Scope and Segmentation

Report Attribute

Details

Market size value in 2021

USD 14.13 billion

Revenue forecast in 2031

USD 27.16 billion

Growth Rate

CAGR of 6.4% from 2021 to 2031

Base year for estimation

2021

Quantitative units

Revenue in USD million and CAGR from 2021 to 2031

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

End user, Application and Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Key companies profiled

Nestle SA, Baxter International Inc, Abbott Laboratories, Braun Melsungen AG, GroupeDanone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira Inc, Perrigo Company Plc and Other Prominent Players.

 

 

Frequently Asked Questions (FAQ):

Global Clinical Nutrition Market to surpass USD 27.16 billion by 2031 from USD 14.13 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-31.

A clinical nutrition product is a type of pharmaceutical product that aids in the maintenance of a patient's health. It contributes to the improvement of the metabolic system by providing adequate supplements such as minerals, vitamins, and other nutrients. Clinical nutrition diagnoses and treats diseases that affect the intake, intestinal absorption, and metabolism of dietary constituents, as well as promotes health through diet-related disease prevention.

During the forecasted period, cancer and pediatric segment held the largest market share.

Nestle SA, Baxter International Inc, Abbott Laboratories, Braun Melsungen AG, GroupeDanone

The rise in the prevalence of metabolic disorders, high healthcare spending, and the rise of the middle class in emerging economies are driving the global clinical nutrition market's growth. Furthermore, the growing elderly population and the development of clinical nutrition products tailored to the needs of the elderly are expected to fuel market growth.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients